Findings in the Area of Cardiovascular Diseases and Conditions Reported from Dickinson and Company (Relationship between medication adherence and other Medicare star rating measures): Cardiovascular Diseases and Conditions

2025 DEC 10 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Investigators publish new report on Cardiovascular Diseases and Conditions. According to news reporting originating in San Diego, California, by NewsRx journalists, research stated, “To assess the interrelation between Medicare Star Ratings medication adherence measures and other intermediate and process measures. A cross-sectional analysis was performed of the annual Medicare Star Ratings health plan performance data from Star Ratings years 2015-2025.”

The news reporters obtained a quote from the research from Dickinson and Company, “The analysis evaluated the potential relationship between (1) renin-angiotensin system antagonist (RASA) adherence and controlling blood pressure, (2) noninsulin antidiabetic adherence and controlling blood glucose, (3) statin adherence and statin therapy for patients with cardiovascular disease (CVD), and (4) statin adherence and statin use in persons with diabetes (SUPD). The outcomes of interest were ORs and 95% CIs evaluating the likelihood of a health plan achieving 5 stars or at least 4 stars on the intermediate or process measures if they achieved 5 stars or at least 4 stars on the medication adherence measures compared with not achieving 5 stars or at least 4 stars on the medication adherence measures. Plans that achieved 5 stars on the antidiabetic adherence measure and RASA adherence measure had significantly higher odds of achieving 5 stars on their respective intermediate measures (blood glucose control: OR, 3.50; 95% CI, 2.98-4.12; blood pressure control: OR, 4.61; 95% CI, 3.82-5.60). Plans that achieved 5 stars on the statin adherence measure had significantly higher odds of achieving 5 stars on statin therapy for patients with CVD and SUPD (CVD: OR, 4.68; 95% CI, 3.49-6.27; SUPD: OR, 4.37; 95% CI, 3.26-5.85). Medicare Star Ratings medication adherence measures are significantly tied to intermediate and statin process measures.”

According to the news reporters, the research concluded: “Targeted interventions to improve adherence should be a key strategy for health plans to enhance both clinical outcomes and financial incentives.”

This research has been peer-reviewed.

For more information on this research see: Relationship between medication adherence and other Medicare star rating measures. The American Journal of Managed Care, 2025;31(11):688-692. The American Journal of Managed Care can be contacted at: Managed Care & Healthcare Communications Llc, 666 Plainsboro Rd, Ste 300, Plainsboro, NJ 08536, USA.

Our news correspondents report that additional information may be obtained by contacting Eric P. Borrelli, Becton, Dickinson and Company, 3750 Torrey View Ct, San Diego, CA 92130. Additional authors for this research include Peter Saad, Nathan E. Barnes, Idal Beer and Julia D. Lucaci.

The publisher of the The American Journal of Managed Care can be contacted at: Managed Care & Healthcare Communications Llc, 666 Plainsboro Rd, Ste 300, Plainsboro, NJ 08536, USA.

(Our reports deliver fact-based news of research and discoveries from around the world.)